Revenue (Tables)

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2020	2019	2020	2019
Biologics	32 %	26 %	29 %	25 %
Generics	18 %	20 %	19 %	20 %
Pharma	27 %	30 %	28 %	31 %
Contract-Manufactured Products	23 %	24 %	24 %	24 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2020	2019	2020	2019
High-Value Components	47 %	42 %	45 %	43 %
Standard Packaging	25 %	28 %	26 %	29 %
Delivery Devices	5 %	6 %	5 %	4 %
Contract-Manufactured Products	23 %	24 %	24 %	24 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2020	2019	2020	2019
Americas	49 %	48 %	49 %	48 %
Europe, Middle East, Africa	42 %	44 %	43 %	44 %
Asia Pacific	9 %	8 %	8 %	8 %
	100 %	100 %	100 %	100 %

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2019	$	9.8
Contract assets, September 30, 2020	16.2
Change in contract assets - increase (decrease)	$	6.4
Deferred income, December 31, 2019	$	(34.9)
Deferred income, September 30, 2020	(56.7)
Change in deferred income - decrease (increase)	$	(21.8)